Syngene International (NSE:SYNGENE) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SYNGENE Syngene International Ltd NSE:SYNGENE
82 GF Score
Price ₹382.65
GF Value ₹724.33
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Syngene International Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:SYNGENE
82GF Score
Syngene International Ltd NSE:SYNGENE
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Syngene International (NSE:SYNGENE) Overvalued in 2026?

Based on GuruFocus' analysis, Syngene International stock appears to be undervalued. The current stock price of ₹382.65 is trading 47.2% below its estimated GF Value™ of ₹724.33. GuruFocus considers Syngene International to be Significantly Undervalued.

Key valuation signals for NSE:SYNGENE:

  • Short Ratio:
  • GF Value™: ₹724.33 vs. price of ₹382.65 (47.2% below fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the NSE:SYNGENE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Syngene International Business Description

Other Exchanges 539268:India
Address Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The Company is engaged in a single operating segment of providing contract research and manufacturing services. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the USA. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.
82GF Score

Get the complete analysis for NSE:SYNGENE

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹382.65
Price
₹724.33
GF Value